Abstract:Neurodegenerative disease characterized by the progressive damage of the nervous system, and neuropathies caused by the neuronal injury are both led to substantial impairments in neural function and quality of life among geriatric populations. Recovery from nerve damage and neurodegenerative diseases present a significant challenge, as the central nervous system (CNS) has limited capacity for self-repair. Investigating mechanism of neurodegeneration and regeneration is essential for advancing our understanding and development of effective therapies for nerve damage and degenerative conditions, which can significantly enhance patient outcomes. Collapsin response mediator protein 2 (CRMP2) was first identified as a key mediator of axonal growth and guidance is essential for neurogenesis and neuroregeneration. Phosphorylation as a primary modification approach of CRMP2 facilitates its involvement in numerous physiological processes, including axonal guidance, neuroplasticity, and cytoskeleton dynamics. Prior research on CRMP2 phosphorylation has elucidated its involvement in the mechanisms of neurodegenerative diseases and nerve damage. Pharmacological and genetic interventions that alter CRMP2 phosphorylation have shown the potential to influence neurodegenerative diseases and promote nerve regeneration. Even with decades of research delving into the intricacies of CRMP2 phosphorylation, there remains a scarcity of comprehensive literature reviews addressing this topic. This absence of synthesis and integration of findings hampers the field's progress by preventing a holistic understanding of CRMP2's implications in neurobiology, thereby impeding potential advancements in clinical treatments and interventions. This review intends to compile investigations focused on the role of CRMP2 phosphorylation in both neurodegenerative disease models and injury models to summarizing impacts and offer novel insight for clinical therapies.

Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications

CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases

Unraveling the Nexus: The Role of Collapsin Response Mediator Protein 2 Phosphorylation in Neurodegeneration and Neuroregeneration

CRMP2 Participates in Regulating Mitochondrial Morphology and Motility in Alzheimer's Disease

The Regulatory and Enzymatic Functions of CRMPs in Neuritogenesis, Synaptic Plasticity, and Gene Transcription.

Tat-Collapsin Response Mediator Protein 2 (CRMP2) Increases the Survival of Neurons After NMDA Excitotoxity by Reducing the Cleavage of CRMP2

Molecular dynamics simulations and in vitro analysis of the CRMP2 thiol switch

Brain-Specific Crmp2 Deletion Leads To Neuronal Development Deficits And Behavioural Impairments In Mice

DPYSL2/CRMP2 isoform B knockout in human iPSC-derived glutamatergic neurons confirms its role in mTOR signaling and neurodevelopmental disorders

Camkii Phosphorylates Collapsin Response Mediator Protein 2 and Modulates Axonal Damage During Glutamate Excitotoxicity

Collapsin Response Mediator Protein 2 and Endophilin2 Coordinate Regulation of AMPA Receptor GluA1 Subunit Recycling

Phosphorylation of CRMP2 by Cdk5 Negatively Regulates the Surface Delivery and Synaptic Function of AMPA Receptors

CRMP2 modulates mossy fiber sprouting in dentate gyrus of pilocarpine induced rat model of epilepsy

Distribution of different phosphorylated forms of CRMP2 in hippocampal neurons and their effect on neurites growth of hippocampal neurons in rats

CRMP2 improves memory deficits by enhancing the maturation of neuronal dendritic spines after traumatic brain injury.

Role of Collapsin-Response Mediator Protein 2 in the Development of Epileptic Seizures in Clinics and Experimental Models

[CRMP2 binding compound accelerates functional recovery from central nervous system damage]

Crmp4 And Crmp2 Interact To Coordinate Cytoskeleton Dynamics, Regulating Growth Cone Development And Axon Elongation

GSK‐3α/β‐mediated Phosphorylation of CRMP‐2 Regulates Activity‐dependent Dendritic Growth

The Involvement of CRMP-2 on Axonal and Dendrictic Injury after Hypoxic-Ischemic Brain Injury in Neonatal Rat]

Monoallelic CRMP1 gene variants cause neurodevelopmental disorder